US Patent Issued to RedHill Biopharma on Feb. 17 for "Sphingosine kinase 2 inhibitor for treating coronavirus infection" (American, Israeli Inventors)

ALEXANDRIA, Va., Feb. 17 -- United States Patent no. 12,551,469, issued on Feb. 17, was assigned to RedHill Biopharma Ltd. (Tel-Aviv, Israel).

"Sphingosine kinase 2 inhibitor for treating coronavirus infection" was invented by Dror Ben-Asher (Tel-Aviv, Israel) and Reza Fathi (Oradell, N.J.).

According to the abstract* released by the U.S. Patent & Trademark Office: "The disclosure is directed to ABC294640, as free base or as salts thereof, in preparing medicines for treating coronavirus infection or preventing diseases caused by coronavirus infection, and a medicine for preventing coronavirus infection or preventing diseases caused by coronavirus infection."

The patent was filed on June 30, 2021, under Application No. 17/364,386.

*For f...